Juan Pablo (JP) Arab, MD  Profile Banner
Juan Pablo (JP) Arab, MD  Profile
Juan Pablo (JP) Arab, MD 

@juanpabloarab

Followers
4,227
Following
1,780
Media
547
Statuses
5,033

Transplant Hepatologist & Clinical Researcher at @WesternU . @FacMedicinaUC & @MayoClinic alumni. Love photography. Interests: #ALD #MASLD #Transplant .  = mine

Joined November 2015
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Beyond thrilled to share our article on #Alcohol -Associated Hepatitis in @NEJM Feel honored to stand between 2 giants & great #mentors . We dedicate this to our patients, let's continue advancing the #science & fighting the #stigma of #ALD #LiverTwitter
@rabataller
Ramon Bataller
1 year
Happy to share with you our review on ALCOHOL-ASSOCIATED HEPATITIS, published today in the @NEJM . We dedicate it to all our patients. We will continue to work together to beat it. @Dr_Vijay_Shah @juanpabloarab #LiverTwitter #MedTwitter
Tweet media one
70
467
2K
15
23
200
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Do you need to update your knowledge of the Diagnosis and Management of Cirrhosis and Its Complications? Here is a review by the great @ebtapper in @JAMA_current #MedTwitter #GITwitter #LiverTwitter
Tweet media one
3
42
181
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Beyond thrilled to share our article on #Alcohol -Associated Hepatitis in @NEJM Feel honored to stand between 2 giants & great #mentors . We dedicate this to our patients, let's continue advancing the #science & fighting the #stigma of #ALD #LiverTwitter
@NEJM
NEJM
1 year
Alcohol use disorder is a major cause of advanced liver disease worldwide. Bataller and colleagues review the epidemiology, pathophysiology, and treatment of alcohol-associated hepatitis including the evidence for steroids and liver transplantation.
Tweet media one
15
470
1K
17
25
172
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Our article "MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis" @JHEP_Reports ✅MELD 3.0 was the best predictor of renal replacement therapy requirements #LiverTwitter
Tweet media one
1
47
122
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Now online "Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation" at @NatRevGastroHep ✅ Discuss pharmacotherapy for AUD in the LT setting ✅ Review behavioral therapies ✅ Propose a definition for relapse
7
32
118
@juanpabloarab
Juan Pablo (JP) Arab, MD 
6 months
Our paper by @LuisAntonioDiaz et al. New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease! Now online in @HEP_Journal
Tweet media one
3
37
113
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Our latest study IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY online at @JHepatology #LiverTwitter #ALDsig #MedTwitter #GITwitter @LuisAntonioDiaz
Tweet media one
2
41
106
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Are you interested in pursuing an #academic career in #Hepatology ? #LiverTwitter ✅I invite you to apply to our Advanced Hepatology Clinical Research Fellowship at @WesternU 📩If interested, please email us at hepatology.western @gmail .com
Tweet media one
2
34
100
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
I feel fortunate to have had the opportunity of visiting @Stanford_GI and delivering Grand Rounds on #ALD . Amazing place with even most amazing people. Plus, I was lucky to see 2 of my fav lebaneses after 4 years! I’m taking some sunshine back home with me #LiverTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
3
89
@juanpabloarab
Juan Pablo (JP) Arab, MD 
17 days
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease? ☝️VERY important question ✌️ Especially in those individuals with liver disease 🚨 Limits are probably lower than what we previously thought Thanks @mromerogomez for the…
Tweet media one
1
36
88
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
This picture means a lot… seeing friends and mentors in person after so long… thanks @AASLDtweets for the amazing ETC conference on #ALD ! #LiverTwitter
Tweet media one
0
3
84
@juanpabloarab
Juan Pablo (JP) Arab, MD 
5 months
My birthday gift from my amazing transplant coordinators! They know I love coffee, red color, and it seems I say “Oh lord!” too often! 🤣☕️ #LiverTwitter @WesternU @westernuGI @mqkMD @Hailem_desalegn @Moalsager @CaroRamirezMD
Tweet media one
12
0
83
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Hey #LiverTwitter tomorrow is THE big day: 1st day of #TLMdX and MY BIRTHDAY 🥳! @AASLDtweets can I have a cake like this? @manhalizzy @BenyamDAddissie @LorettaJophlin
Tweet media one
16
1
83
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Entrevista en CNN Chile y Chilevisión respecto al Premio Nobel por el descubrimiento del Virus de la Hepatitis C @FacMedicinaUC @ucchristus @ACHHEPChile @schgastro @sochtx @alehlatam
Tweet media one
3
6
82
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
New nomenclature for NAFLD: Metabolic-dysfunction associated steatotic liver disease. Just released at #EASLCongress @AASLDtweets @EASLnews @alehlatam @marurinella #LiverTwitter
Tweet media one
@rabataller
Ramon Bataller
10 months
This is my minimalist view of the new #NAFLDnomenclature : 🔸Mostly metabolic: MASLD 🔸Dual metabolic & alcohol: MetALD 🔸Mostly alcohol: ALD #EASLCongress @EASLedu @EASLnews @AASLDtweets @alehlatam @marurinella @GCastro_NarroMD @norahterrault
Tweet media one
8
103
245
1
28
80
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
#LiverTwitter Our article "MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis" in @JHEP_Reports is now available online here:
Tweet media one
1
24
81
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 months
Thanks @JHepatology for highlighting our article on the cover! Strong work by @LuisAntonioDiaz 🌟🌟 #LiverTwitter
@JHepatology
Journal of Hepatology
2 months
📢Check our March issue ‼️ Featured article: 💥Global Impact of #PublicHealthPolicies on Alcohol ➡️By @LuisAntonioDiaz , Eduardo Fuentes-López et al. 🔗 Full issue here👉 #LiverTwitter @EASLEUAffairs @EASLnews @EASLedu
Tweet media one
2
13
37
5
9
75
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Beautiful view of Santiago, Chile 🇨🇱
Tweet media one
Tweet media two
5
4
76
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
Rivaroxaban improves liver decompensation in cirrhosis 🤔in whom? When to start? Is rivaroxaban the best option in cirrhosis? For how long? Many questions ❓⁉️ #LiverTwitter
Tweet media one
2
15
75
@juanpabloarab
Juan Pablo (JP) Arab, MD 
8 months
Tweet media one
11
10
76
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Our article by @FcoIdalsoaga "Current and emerging therapies for #alcohol -associated #hepatitis " in Liver Research #LiverTwitter
Tweet media one
0
20
76
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 months
Honored to have visited @Yale Liver Center. Thank you very much @ggarciatsao @lykhaque @MichaelNathanso I really enjoyed the hospitality and the beautiful campus. @MarcoArreseMD #LiverTwitter
Tweet media one
2
2
74
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
True or not true? 🤣 #MedTwitter #LiverTwitter
Tweet media one
1
12
75
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Finally, @DGlaucomflecken first day of Gastroenterology! #GITwitter #LiverTwitter ... now I’d like to see the First day of Hepatology!
2
7
73
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
#MASLD / #MASH drugs in the pipeline are many! Promising data in: ✅GLP1 R agonists ✅SGLT2 inhib ✅Those linked to BAs (FXR, FGF19, FGF21, TGR5) ✅… And many more! Looking forward to what the future will bring #LiverTwitter
Tweet media one
2
11
74
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
No se pierdan XXVIII Congreso ALEH 2023 29 de agosto hasta el 1 de septiembre Bogotá, Colombia!! 🇨🇴 @alehlatam #LiverTwitter Más info e inscripciones acá 👇👇👇
Tweet media one
1
22
72
@juanpabloarab
Juan Pablo (JP) Arab, MD 
6 months
Tweet media one
4
8
72
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Enjoying my birthday and @AASLDtweets #TLMdX ... thanks to my extraordinary bunch of IM and GI fellows! @jnchahuan @LuisAntonioDiaz @CokeArnold1
18
1
71
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
2022 has been a great year for the #ALD field… here our summary with @rabataller in @NatRevGastroHep #LiverTwitter
@NatRevGastroHep
Nature Reviews Gastroenterology & Hepatology
1 year
New content online: Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantation
Tweet media one
3
20
55
4
13
70
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
15
66
@juanpabloarab
Juan Pablo (JP) Arab, MD 
6 months
A Classic of every year at The Liver Meeting 2023: A picture with my favorite @AASLDFoundation person @JMerrLVR Thanks for all you do for us! #TLM23 #TapSnapDC @AASLDtweets
Tweet media one
1
3
66
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
I couldn’t miss this picture with the #LiverTwitter ’s king THE @ebtapper himself! #ILC2022 @EASLnews
Tweet media one
1
2
66
@juanpabloarab
Juan Pablo (JP) Arab, MD 
7 months
Ya en Buenos Aires para compartir con los amigos de la @SAHEpatologia . No se pierdan el excelente programa que parte mañana con el curso precongreso! #LiverTwitter
Tweet media one
5
1
64
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Every time I learn from Dr Kamath I feel a little bit smarter and uplifted :) A true giant of our field #LiverMtg21 #TLMdX @AASLDtweets @MayoClinicGIHep @manhalizzy @BenyamDAddissie @LorettaJophlin @DougSimonetto @Dr_Vijay_Shah
Tweet media one
3
6
64
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Our paper addressing the role of hepatic stellate cells regulating hepatocyte steatohepatitis that precedes liver fibrosis in ALD, is now online @Dr_Vijay_Shah @tejasavsehrawat @NJSakrikar @rhuebert @vikasverma20 @JHepatology @EASLnews #ALDSIG #ALDLIT
Tweet media one
6
10
63
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
#EASLCongress has finished, but I’ll keep the best memories of seeing amazing friends in person #LiverTwitter @AASLDtweets @EASLnews @alehlatam
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
8
59
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
No se pierdan mañana al extraordinario @rabataller hablando sobre: "Manejo integral de la enf hepática por alcohol" para @ACHHEPChile #LiverTwitter Gratis a través del Youtube de @schgastro @raulazarte @jproblero
Tweet media one
1
23
57
@juanpabloarab
Juan Pablo (JP) Arab, MD 
12 days
🚨NEW from @GlobalAlcHep 🚨 @HEP_Journal #WinstonDunn et al. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study ✅ Harnessing AI within a global consortium, we pioneered a scoring system excelling over…
Tweet media one
2
23
81
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 months
Just published! Dave Hudson et al. " #Addiction and #Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management" @SpringerCurRpts #LiverTwitter
Tweet media one
1
20
57
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Exciting results for #NAFLD field in @NEJM ... 85% had a weight loss of at least 5% with the lower dose (5 mg), 91% with 15mg weekly. Tirzepatide Once Weekly for the Treatment of Obesity #LiverTwitter @NoureddinMD @DrLoomba @MarcoArreseMD @LuisAntonioDiaz
1
14
57
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
4
7
54
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Tweet media one
2
5
54
@juanpabloarab
Juan Pablo (JP) Arab, MD 
5 months
Did you miss the State-of-the-art lecture: "MASLD: New nomenclature and implications for Liver Transplantation" by the extraordinary @kymwatt ? No worries! You can see it here: #LiverTwitter
Tweet media one
1
11
54
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Isn't Santiago pretty after the rain? The majestic Andes Mountains from my window #LiverTwitter #GITwitter @LuisAntonioDiaz @MarcoArreseMD @AlejandroSoza @FcoIdalsoaga @CokeArnold1
Tweet media one
3
2
54
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
A perfect cake for an amazing woman 👩, extraordinary doctor 👩‍⚕️, badass mom 👨‍👩‍👦‍👦, awesome wife 💍 (although she needs a Twitter account 😂)... gifted to her by a nurse. #MedTwitter #GITwitter #LiverTwitter
Tweet media one
3
2
54
@juanpabloarab
Juan Pablo (JP) Arab, MD 
6 months
My famous friend @JVLazarus is everywhere! Always good to see u in person #TLM23 @AASLDtweets @EASLnews @alehlatam @liverUSA #LiverTwitter
Tweet media one
0
2
53
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Ready to start @AASLDtweets #LiverMtg21 #TLMdX less than 1 hour until @AASLDPresident kick it off! My office remembering me the continuous support from @AASLDFoundation and the @AASLDtweets
Tweet media one
3
5
53
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Join the session: #Liver Transplantation and #Alcohol -Associated Liver Disease: Where Are We in 2022? at #ILTS2022 @_ILTS_ #LiverTwitter @mariana_mlazo @NaziaSelzner @manhalizzy
Tweet media one
Tweet media two
Tweet media three
2
6
52
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Thanks @uamshealth @MaugarMD for the invitation to @UAMS_GutClub . I really enjoyed the opportunity to interact with new and old friends. #LiverTwitter #ALDcure
Tweet media one
Tweet media two
1
3
51
@juanpabloarab
Juan Pablo (JP) Arab, MD 
5 months
Just published our article Advances in the diagnosis and management of hepatorenal syndrome: insights into HRS-AKI and liver transplantation #LiverTwitter @CokeArnold1 @FcoIdalsoaga @gu_ayares @mqkMD
@eGastro_BMJ
eGastroenterology
5 months
📢 Our latest review article by Prof. Arab and his colleagues from Western University, Canada, is now live! 🚀Dive into cutting-edge research at the intersection of nephrology and liver transplantation. 📚 👉 @FrontGastro_BMJ @BMJOpen_Gastro
Tweet media one
1
10
23
1
17
50
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Our article in @JHepatology describing the role of HSCs in alcohol-related hepatitis @Dr_Vijay_Shah @rhuebert @NJSakrikar @tejasavsehrawat
2
11
49
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
2 years
New Health Policy - Diaz et al - The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas #NAFLD #fattyliver @LuisAntonioDiaz @ALEH
Tweet media one
0
16
35
2
9
50
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 months
Thanks @UAlbertaGI for the invitation. I was amazed by the stellar group of Academic Hepatologists… such an example! I learned a lot! And brought you some good weather 😎🤣 Many opportunities for collaboration. Thanks and hope to see you all again soon! #LiverTwitter #GITwitter
Tweet media one
Tweet media two
Tweet media three
4
1
48
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Last week we finished the first Program For Advanced Training Of Hepatologists In Alcohol Use Disorder Management (PRATHAM). Highly recommended to every hepatologist caring for pts with AUD. Thanks to the organizers! @vknNIMHANS_ECHO
Tweet media one
3
9
48
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Tweet media one
0
0
49
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
@JHepatology
Journal of Hepatology
2 years
Worldwide study: Corticosteroids improve 30-day survival among patients with severe alcohol-associated #hepatitis , especially with MELD scores between 25 and 39 By @juanpabloarab & @LuisAntonioDiaz & colleagues➡️
Tweet media one
0
21
52
2
10
47
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Just online! Vaccination against #COVID -19 decreases hospitalizations in patients with #cirrhosis : Results from a nationwide analysis @LiverInt @LuisAntonioDiaz @MarcoArreseMD @mariana_mlazo #LiverTwitter
Tweet media one
2
9
47
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Definition of academic luxury: "Having Dr. @jaumebosch9 giving Grand Rounds at your Department" Thanks for this incredible and inspirational talk! #livertwitter @FacMedicinaUC @MarcoArreseMD @AlejandroSoza
Tweet media one
3
4
47
@juanpabloarab
Juan Pablo (JP) Arab, MD 
5 months
Liver transplantation in Latin America: reality and challenges @DraMarianaCh @hernandezliver @MMendizabalMD #LiverTwitter
0
12
46
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Dr. @docMPK talking about #heart -liver axis, very nice and informative talk! #LiverTwitter
Tweet media one
3
23
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
19 days
Don't miss the discussion around MetALD... tomorrow! #LiverTwitter @inedsys
@SanjayaSatapath
Sanjaya Satapathy
20 days
Join us for a virtual State-of-the-art lecture on MetALD and Liver Transplantation by ⁦ @juanpabloarab ⁩ | April 6, 2024, 08:00 AM ET (US and Canada) | 5:30 PM IST | Register: ⁦⁩ @AASLDtweets @AmCollegeGastro @_ILTS_
Tweet media one
0
1
19
2
3
47
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Our article "Identification of Optimal Therapeutic Window for Steroid Use in Severe Alcohol-associated Hepatitis" is published @JHepatology #LiverTwitter #ALDsig @LuisAntonioDiaz @rabataller @MarcoArreseMD @singal_ashwani @JuanAbraldes @Dr_Vijay_Shah
3
19
47
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Because #alcohol not only affects the #Liver … our article: Alcohol Consumption: Medical Implications, the Liver and Beyond @CokeArnold1 @LuisAntonioDiaz @FcoIdalsoaga @DeepikaDevuniMD #LiverTwitter Read it here:
Tweet media one
1
14
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Always a pleasure to hang out with ⁦ @rabataller ⁩ at #AEEH2023 #LiverTwitter
Tweet media one
2
2
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
This is the best part of attending @_ILTS_ ! #LiverTwitter family
Tweet media one
1
0
46
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 months
Very comprehensive review about Liver Transplantation… Don’t miss some of the key concepts including the “transplant window” #LiverTwitter
@JCEH_Hepatology
Journal of Clinical and Experimental Hepatology
3 months
Liver Transplantation in chronic liver disease and acute on chronic liver disease- Indication, Timing and Practices A comprehensive review by @ashok_doctor et al #LiverTwitter #Transplant
Tweet media one
1
36
61
3
11
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
@LuisAntonioDiaz representing us ( #LiverTwitter ) in the @WHO Forum on alcohol, drugs, and addictive behaviors in Geneva 🇨🇭 Integration is key to help our patients and move the field forward #ALDCure @AASLDtweets @EASLnews @alehlatam
Tweet media one
Tweet media two
2
12
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Our paper now online! An Open Label, Dose Escalation Study To Assess The Safety And Efficacy Of IL‐22 Agonist F‐652 In Patients With Alcoholic Hepatitis @Dr_Vijay_Shah @nagachalasani @hmalhi @DougSimonetto @tejasavsehrawat @hevargasmd @vikasverma20
6
6
45
@juanpabloarab
Juan Pablo (JP) Arab, MD 
10 months
Tweet media one
2
1
44
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Review: The use of Rifaximin in Patients with Cirrhosis, by Caraceni P. et al. in @HEP_Journal @AASLDtweets What do u think about using it for SBP prophylaxis? @JasmohanBajaj @ebtapper @manhalizzy @LorettaJophlin @JuanAbraldes @gmezzanop
Tweet media one
2
12
43
@juanpabloarab
Juan Pablo (JP) Arab, MD 
8 months
@rabataller presenting tips on mentoring 1 Be prepared 2 Personalized 3 Regular follow-up meetings 4 Knowing your mentee 5 Give space 6 Confidence/Flexibility 7 Advocate 8 Learn from your mentee 9 Complete the work on time 10 Independence #LiverTwitter @alehlatam @AASLDtweets
Tweet media one
0
10
42
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Tweet media one
0
4
42
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 months
Glad to be able to participate from #CLM24 @CASLupdates in Toronto and see many friends #LiverTwitter
Tweet media one
Tweet media two
0
1
42
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
3
5
42
@juanpabloarab
Juan Pablo (JP) Arab, MD 
8 months
Ahora @DrJavierCrespo presentando sobre herramientas diagnosticas no invasivas para evaluar fibrosis e hipertensión portal en MASH @alehlatam #ALEH2023 ✅GPVH se correlaciona con mortalidad ✅Posibilidad de reversibilidad y recompensación
Tweet media one
0
10
41
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 months
Our very own star Hepatologist @mqkMD talking about #MASLD at the London Liver Update 2024 @WesternU @VPRWesternU @westernuGI #LiverTwitter
Tweet media one
2
2
40
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Great way to start the @CASLupdates STC on Alcohol… Sightseeing Vancouver! #LiverTwitter #BetterTogether #CASLSTC22
Tweet media one
Tweet media two
Tweet media three
2
1
40
@juanpabloarab
Juan Pablo (JP) Arab, MD 
5 months
Tweet media one
1
3
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
After working more than 1 year together for the @alehlatam meeting. I was finally able to meet @ezerid in person! #Devirtualized at #TLM22 @AASLDtweets
Tweet media one
1
1
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Hoy fue el último día de residencia de #Gastroenterologia de @LuisBus71253984 , @TEMUCOHHHA es afortunado de recibir un profesional como tu! Éxito en todo y siempre cuenta con nosotros! @FacMedicinaUC @ucatolica @ucchristus @schgastro @AlejandroSoza @jnchahuan @LuisAntonioDiaz
Tweet media one
7
0
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Brian Lee (who urgently needs a Twitter account) presenting Identifying Risk of Alcohol Use Recurrence after Liver Transplantation @_ILTS_ #ILTS2023
Tweet media one
1
3
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
Tweet media one
1
6
38
@juanpabloarab
Juan Pablo (JP) Arab, MD 
4 years
Extraordinary talk by Michael Trauner on PBC! How to manage fatigue and pruritus? Here the answers #LiverMtg19 @AASLDtweets
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
14
35
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 months
Excellent comment #NewsandViews on our @JHepatology article. It is time to take actions to reduce alcohol-related burden at a population level #LiverTwitter @LuisAntonioDiaz @rabataller @JVLazarus @MarcoArreseMD
@NatRevGastroHep
Nature Reviews Gastroenterology & Hepatology
2 months
HEALTH POLICY | Evidence-based #alcohol policies are the answer #NewsandViews by William Gilmore & Ian Gilmore Read it here
Tweet media one
0
5
8
0
13
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
The best one @hmalhi discussing on how to apply ALD knowledge to NAFLD at #TLM22 @AASLDtweets #LiverTwitter
Tweet media one
2
6
38
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 year
Starting the #ALDsig debrief session. @TiffanyWuMD presenting her study on acamprosate for AUD #TLM22 #LiverTwitter @AASLDtweets @LuisAntonioDiaz
Tweet media one
1
6
39
@juanpabloarab
Juan Pablo (JP) Arab, MD 
2 years
NAFLD Consensus just starting! #LiverTwitter @AASLDtweets ⁩ ⁦ @EASLnews ⁩ ⁦ @EASLedu ⁩ ⁦ @alehlatam
Tweet media one
0
3
38
@juanpabloarab
Juan Pablo (JP) Arab, MD 
7 months
Congratulations @FcoIdalsoaga on this much-needed paper for LatinAmerica: "Active alcohol consumption is associated with Acute-on-Chronic Liver Failure in Hispanic patients" at @gastroHepato #LiverTwitter @LuisAntonioDiaz @MarcoArreseMD @gmezzanop
Tweet media one
Tweet media two
0
11
38
@juanpabloarab
Juan Pablo (JP) Arab, MD 
3 years
Dr. @LuisAntonioDiaz presenting our data at the @alehlatam meeting plenary session! Proud of you!
Tweet media one
Tweet media two
Tweet media three
3
6
37
@juanpabloarab
Juan Pablo (JP) Arab, MD 
11 months
Hey #MedTwitter #GITwitter #LiverTwitter today is #NASHday Let’s continue working together on tackling this disease! We need a multidisciplinary and society approach!
Tweet media one
1
10
38